Treatment of advanced carcinoma of the cervix with adriamycin and methotrexate combined.
D000328:Adult; D000505:Alopecia / Q000139:chemically induced; D001007:Anxiety / Q000139:chemically induced; D001835:Body Weight / Q000187:drug effects; D001853:Bone Marrow / Q000187:drug effects; D002277:Carcinoma / Q000188:drug therapy* / Q000401:mortality; D004317:Doxorubicin / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D008875:Middle Aged; D009059:Mouth Diseases / Q000139:chemically induced; D009325:Nausea / Q000139:chemically induced; D009362:Neoplasm Metastasis; D012075:Remission, Spontaneous; D013649:Taste / Q000187:drug effects; D013924:Thrombophlebitis / Q000139:chemically induced; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy* / Q000401:mortality
D004317:Doxorubicin; D008727:Methotrexate